Dealmaking Quarterly Statistics, Q1 2021: Boston Scientific, Roche Start The Year With Billion-Dollar-Plus Acquisitions
A Look At M&A And Alliance Activity Across Medical Device And In Vitro Diagnostics Industries, January-March 2021
Executive Summary
During the first quarter, medical device company mergers and acquisition totalled $10.2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $5bn.
You may also be interested in...
Genomic Sequencing Company Element Biosciences Raises $276M
The funding round drew a wide range of supporters and raised enough money to allow Element to expand its San Diego-based operations.
Boston Scientific Shoots For Cardiac Ablation Leadership With $387M Farapulse Acquisition
Boston Scientific will exercise its option to buy the remaining 73% of Farapulse, the first company to market a pulsed field cardiac ablation system.
Diagnostics Saves Roche From Q1 Difficulties
In its first quarter 2021 sales earnings report, Roche highlighted the strength of its diagnostics business as biosimilars cannibalize its pharmaceutical revenues.